• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗NC16a IgG和IgE自身抗体的酶联免疫吸附测定指数与大疱性类天疱疮的严重程度和活动度相关。

Enzyme-linked Immunoassay Index for Anti-NC16a IgG and IgE Auto-antibodies Correlates with Severity and Activity of Bullous Pemphigoid.

作者信息

Kalowska Monika, Ciepiela Olga, Kowalewski Cezary, Demkow Urszula, Schwartz Robert A, Wozniak Katarzyna

机构信息

Department of Dermatology and Immunodermatology , Medical University of Warsaw, Warsaw, Poland.

出版信息

Acta Derm Venereol. 2016 Feb;96(2):191-6. doi: 10.2340/00015555-2101.

DOI:10.2340/00015555-2101
PMID:25791894
Abstract

Bullous pemphigoid (BP) is characterized by IgG and IgE autoantibodies to the NC16a domain of BP180. This study evaluated the correlation between body surface area (BSA), total serum IgE and enzyme-linked immunoassay (ELISA) for IgG and IgE anti-NC16a in 77 patients with BP in the active stage, and the degree of conversion to negative of the studied parameters in clinical remission. Statistically positive correlations were observed between BSA and examined parameters (correlation index 0.2548, 0.2491, 0.311, respectively). Originally, patients with BP with positive ELISAs for both IgG and IgE autoantibodies presented twice as extensive skin lesions as those with positive IgG and negative IgE ELISAs. Conversion of ELISAs for IgG and IgE to negative in clinical remission occurred in 9.3% and 81% of patients with BP, respectively. This confirmed that ELISA for IgE anti-NC16a is a helpful parameter in the modification of current treatment and the assessment of risk of relapse in BP.

摘要

大疱性类天疱疮(BP)的特征是存在针对BP180的NC16a结构域的IgG和IgE自身抗体。本研究评估了77例活动期BP患者的体表面积(BSA)、血清总IgE以及IgG和IgE抗NC16a酶联免疫吸附测定(ELISA)之间的相关性,以及临床缓解期研究参数的转阴程度。观察到BSA与检测参数之间存在统计学上的正相关(相关指数分别为0.2548、0.2491、0.311)。最初,IgG和IgE自身抗体ELISA均为阳性的BP患者皮肤病变范围是IgG ELISA阳性而IgE ELISA阴性患者的两倍。临床缓解期,BP患者中IgG和IgE ELISA转阴的比例分别为9.3%和81%。这证实了IgE抗NC16a ELISA在调整当前治疗方案及评估BP复发风险方面是一个有用的参数。

相似文献

1
Enzyme-linked Immunoassay Index for Anti-NC16a IgG and IgE Auto-antibodies Correlates with Severity and Activity of Bullous Pemphigoid.抗NC16a IgG和IgE自身抗体的酶联免疫吸附测定指数与大疱性类天疱疮的严重程度和活动度相关。
Acta Derm Venereol. 2016 Feb;96(2):191-6. doi: 10.2340/00015555-2101.
2
Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.IgE 自身抗体对 BP180 的血清水平与大疱性类天疱疮疾病活动的相关性。
JAMA Dermatol. 2017 Jan 1;153(1):30-38. doi: 10.1001/jamadermatol.2016.3357.
3
Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.大疱性类天疱疮患者血清中抗BP180和抗BP230自身抗体的水平。
J Dermatol Sci. 2008 Feb;49(2):153-61. doi: 10.1016/j.jdermsci.2007.08.008. Epub 2007 Oct 24.
4
Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.在大疱性类天疱疮早期,抗BP180 NC16A IgE水平与疾病严重程度无关。
Arch Dermatol Res. 2015 Nov;307(9):849-54. doi: 10.1007/s00403-015-1598-3. Epub 2015 Sep 24.
5
Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system.使用 ISAC® 微阵列系统检测 IgG 和 IgE 对 BP180 的反应性。
Br J Dermatol. 2013 Jun;168(6):1205-14. doi: 10.1111/bjd.12161.
6
IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.在大疱性类天疱疮中,IgG4和IgE是靶向BP180的NC16A结构域的主要免疫球蛋白:这些免疫球蛋白的血清水平反映疾病活动度。
J Am Acad Dermatol. 2000 Apr;42(4):577-83.
7
A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.一种新型酶联免疫吸附测定法显示,大疱性类天疱疮患者中BP180特异性IgE产生的频率很高。
J Immunol Methods. 2009 Jul 31;346(1-2):18-25. doi: 10.1016/j.jim.2009.04.013. Epub 2009 May 5.
8
Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.检测大疱性类天疱疮患者 IgE 自身抗体对 BP180 和 BP230 的反应与其临床特征的关系。
Br J Dermatol. 2017 Jul;177(1):141-151. doi: 10.1111/bjd.15114. Epub 2017 Apr 12.
9
Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.14 例无 IgG 自身抗体针对 BP180 NC16A 域的大疱性类天疱疮患者的临床和免疫学特征。
JAMA Dermatol. 2018 Mar 1;154(3):347-350. doi: 10.1001/jamadermatol.2017.5465.
10
Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.IgE自身抗体与BP180的相关性与严重型大疱性类天疱疮。
Arch Dermatol. 2008 Jan;144(1):41-8. doi: 10.1001/archdermatol.2007.9.

引用本文的文献

1
Bullous pemphigoid.大疱性类天疱疮
Nat Rev Dis Primers. 2025 Feb 20;11(1):12. doi: 10.1038/s41572-025-00595-5.
2
Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid.度普利尤单抗、皮质类固醇及其联合用药治疗大疱性类天疱疮
An Bras Dermatol. 2025 Mar-Apr;100(2):243-252. doi: 10.1016/j.abd.2024.04.012. Epub 2024 Dec 17.
3
Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review).大疱性类天疱疮的病理生理学:2 型炎症的作用和新兴治疗策略(叙述性评论)。
Adv Ther. 2024 Dec;41(12):4418-4432. doi: 10.1007/s12325-024-02992-w. Epub 2024 Oct 19.
4
Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT.研究设计:一项评估度普利尤单抗治疗大疱性类天疱疮成人患者的 2/3 期随机对照试验:LIBERTY-BP ADEPT。
Adv Ther. 2024 Jul;41(7):2991-3002. doi: 10.1007/s12325-024-02810-3. Epub 2024 Mar 5.
5
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.大疱性类天疱疮治疗的进展:全面的药物研发管线更新。
Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29.
6
Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.推进大疱性类天疱疮的治疗:新型治疗靶点和方法的全面综述。
Clin Rev Allergy Immunol. 2023 Dec;65(3):331-353. doi: 10.1007/s12016-023-08973-1. Epub 2023 Oct 28.
7
The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.Eotaxin-1/CCR3 轴和基质金属蛋白酶-9 在抗 NC16A IgE 诱导的大疱性类天疱疮中至关重要。
J Immunol. 2023 Oct 15;211(8):1216-1223. doi: 10.4049/jimmunol.2300080.
8
Necrotizing Fasciitis-Severe Complication of Bullous Pemphigoid: A Systematic Review, Risk Factors, and Treatment Challenges.坏死性筋膜炎-大疱性类天疱疮的严重并发症:系统评价、危险因素和治疗挑战。
Medicina (Kaunas). 2023 Apr 11;59(4):745. doi: 10.3390/medicina59040745.
9
Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid.靶向白细胞介素 4 和白细胞介素 13:天疱疮的一种新治疗方法。
Ann Med. 2023 Dec;55(1):1156-1170. doi: 10.1080/07853890.2023.2188487.
10
Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy.大疱性类天疱疮:2 型炎症在发病机制中的作用及靶向治疗的前景。
Front Immunol. 2023 Feb 16;14:1115083. doi: 10.3389/fimmu.2023.1115083. eCollection 2023.